Hubei Cancer HospitalWuhan, Hubei
Disclosures:
1019 - Neoadjuvant Chemoimmunotherapy Followed by Surgery and Response-Adapted Adjuvant Radiotherapy for Head and Neck Squamous Cell Carcinoma
Monday, September 30, 20245:10 PM – 5:15 PM ET